Patent 9550755 was granted and assigned to Novartis on January, 2017 by the United States Patent and Trademark Office.
The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.